Study limitation: Total combined sample size is 508 (260 + 248 across two stages), not a single cohort; sample size tag reflects the combined total | ReachRx
The Treatment-Related Burnout Scale for Rheumatic Diseases: Development and Preliminary Validation
Study limitation reported by the research below: “Total combined sample size is 508 (260 + 248 across two stages), not a single cohort; sample size tag reflects the combined total.”
